Biopharmaceutical CMO and CRO Market Poised to Growth USD 200 Billion by 2035 with Thriving CAGR of 4.11%
Biotech companies targeting rare diseases often lack the scale for in-house manufacturing or testing. US, NY, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- Biopharmaceutical CMO and CRO Market: Powering the Next Generation of Drug …